Similar articles

• Are PPOs a competitive force or antitrust risk?

  Enders RJ. Enders RJ. Healthc Financ Manage. 1986 May;40(5):52-60. Healthc Financ Manage. 1986. PMID: 10276171
• Physicians and PPOs: antitrust considerations in setting fees.

  Fried JM, Romansky MA. Fried JM, et al. Internist. 1984 Apr;25(4):18, 32. Internist. 1984. PMID: 10266538 No abstract available.
• Physicians and PPOs: antitrust lessons from Maricopa.

  Finke RF, Gary M. Finke RF, et al. Hosp Med Staff. 1983 Jul;12(7):10-5. Hosp Med Staff. 1983. PMID: 10278175 No abstract available.
• Antitrust implications of joint negotiations with third party payers.

  Rainer JM. Rainer JM. Top Health Care Financ. 1986 Winter;13(2):79-85. Top Health Care Financ. 1986. PMID: 3810649 No abstract available.
• Antitrust in the health services industry: the first five years.

  Dolan AK. Dolan AK. Health Med Care Serv Rev. 1981-1982;3(2-3):13, 15-24. Health Med Care Serv Rev. 1981. PMID: 10299261 Review. No abstract available.